At a glance
ClinicalIndex Comparison RecordN/ACompleted· 510 enrolled
Drug / intervention
Trabectedindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trabectedin in Soft Tissue Sarcomas. A Retrospective Observational Analysis (TrObs)
In Brief
An observational study evaluating Trabectedin for Sarcoma, Soft Tissue. Completed, enrolled 510 participants across 26 sites.
Detailed Summary
This is an independent, observational, retrospective post marketing study on the use of trabectedin in a clinical setting. A data collection on the clinical use of the drug will help to improve knowledge and might contribute to optimize the clinical use of the drug.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoma, Soft Tissue
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJun 2016
Primary CompletionOct 2018
TodayJul 2026
First PostedJun 8, 2016
Enrollment StartJun 15, 2016
Primary CompletionOct 2, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.1 years ago
Interventions
Trabectedindrug
Collection of data on the clinical use of Trabectedin